Literature DB >> 11876494

Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats.

F Bolognani1, C J Rumney, B L Pool-Zobel, I R Rowland.   

Abstract

BACKGROUND: Our studies were aimed at investigating the effect of lactic acid producing bacteria (LAB) or inulin, a natural source of non-digestible oligosaccharides derived from chicory, on the induction by carcinogens of aberrant crypt foci (ACF) in the colon, which are considered to be early precursor lesions of neoplasia.
METHODS: Strains of Bifidobacterium longum, Lactobacillus casei and Lactobacillus acidophilus were administered to rats fed a purified high starch diet, under a variety of treatment protocols including daily gavage, via the drinking water and in the diet. The rats were treated with methyl-N-nitrosourea, 1,2-dimethylhydrazine, or azoxymethane (AOM) to induce ACF.
RESULTS: In general, no consistent significant changes in ACF numbers were detected in these experiments. In one study, the basal diet of the rats was changed to one containing a higher level of fat (corn oil). Under these conditions, a significant decrease in AOM-induced colonic ACF was seen in rats given L. acidophilus or inulin. In a concurrent group of animals fed a low fat diet, no significant decrease in ACF was observed.
CONCLUSIONS: The results indicate that the type of diet fed can influence the detection of protective effects of LAB and oligosaccharides and that against the background of a diet with a level of fat typical of a Western diet, evidence for a protective effect of L. acidophilus and inulin towards colon cancer was obtained

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11876494     DOI: 10.1007/s394-001-8359-7

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  12 in total

1.  Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel.

Authors:  S J Langlands; M J Hopkins; N Coleman; J H Cummings
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

2.  Distinct immune response induced by peptidoglycan derived from Lactobacillus sp.

Authors:  Jin Sun; Yong-Hui Shi; Guo-Wei Le; Xi-Yi Ma
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 3.  Ethnomedicinal Uses, Phytochemistry and Pharmacology of Different Cichorium Species (Asteraceae): A Review.

Authors:  Zahra Boghrati; Elaheh Zibaee; Zahra Ayati; Mohammad Sadegh Amiri; Mahin Ramezani; Tannaz Jamialahmadi; Seyed Ahmad Emami; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

Authors:  M Andrea Azcárate-Peril; Michael Sikes; José M Bruno-Bárcena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

Review 5.  New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.

Authors:  Rachna Patel; Herbert L DuPont
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

Review 6.  Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases.

Authors:  Mei Shang; Jun Sun
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

7.  Lack of inhibitory effects of lactic acid bacteria on 1,2-dimethylhydrazine-induced colon tumors in rats.

Authors:  Wei Li; Chong-Bi Li
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

Review 8.  Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk.

Authors:  Derek V Seidel; M Andrea Azcárate-Peril; Robert S Chapkin; Nancy D Turner
Journal:  Semin Cancer Biol       Date:  2017-07-01       Impact factor: 15.707

9.  The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon.

Authors:  Gabriella C van Zanten; Anne Knudsen; Henna Röytiö; Sofia Forssten; Mark Lawther; Andreas Blennow; Sampo J Lahtinen; Mogens Jakobsen; Birte Svensson; Lene Jespersen
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

10.  Probiotics, prebiotics, and synbiotics: gut and beyond.

Authors:  Usha Vyas; Natarajan Ranganathan
Journal:  Gastroenterol Res Pract       Date:  2012-09-19       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.